Literature DB >> 10220504

Role of neurokinin 3 receptors on responses to colorectal distention in the rat: electrophysiological and behavioral studies.

V Julia1, X Su, L Buéno, G F Gebhart.   

Abstract

BACKGROUND & AIMS: Tachykinins contribute to the control of gastrointestinal motility and modulation of somatic and visceral pain. The role of neurokinin (NK) B and NK3 receptors in visceral pain and gastrointestinal disorders has not been determined.
METHODS: Using electromyographic recordings of both abdominal and colonic muscle and electrophysiological recordings of pelvic nerve afferent fibers, we studied drug effects on responses to colorectal distention.
RESULTS: In awake rats, intraperitoneal administration of the NK3-receptor antagonist SR 142,801 reduced, whereas the NK3-receptor agonist senktide increased, both the rectocolonic inhibitory reflex and abdominal contractions produced by colorectal distention. In contrast, intracerebroventricular administration of SR 142,801 increased the number of abdominal contractions without affecting the rectocolonic inhibitory reflex produced by colorectal distention. In a similar manner, intracerebroventricular injection of senktide diminished the number of abdominal contractions. In electrophysiological experiments, SR 142,801 decreased responses of pelvic nerve afferent fibers to colorectal distention. Responses of pelvic nerve fibers to urinary bladder distention, however, were unaffected by SR 142,801.
CONCLUSIONS: These results suggest that peripheral NK3 receptors are involved in the mediation of both visceral nociception and gastrointestinal disorders. Also, central NK3 receptors seem to play a role in the modulation of visceral nociception.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10220504     DOI: 10.1016/s0016-5085(99)70015-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

1.  Inhibitory reflexive effect of rectal distension on postprandial gastric myoelectrical activity.

Authors:  Liwei Qian; William C Orr; J D Z Chen
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 2.  New concepts of irritable bowel syndrome.

Authors:  H R Mertz
Journal:  Curr Gastroenterol Rep       Date:  1999-10

Review 3.  Visceral pain.

Authors:  S K Joshi; G F Gebhart
Journal:  Curr Rev Pain       Date:  2000

Review 4.  Visceral nociception.

Authors:  K N Westlund
Journal:  Curr Rev Pain       Date:  2000

5.  Intestinal inflammation and activation of sensory nerve pathways: a functional and morphological study in the nematode infected rat.

Authors:  R De Giorgio; G Barbara; P Blennerhassett; L Wang; V Stanghellini; R Corinaldesi; S M Collins; G Tougas
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

6.  An open-label trial of theophylline for functional chest pain.

Authors:  Satish S C Rao; Ranjit S Mudipalli; Victor Mujica; Craig L Utech; Xing Zhao; Jeffrey L Conklin
Journal:  Dig Dis Sci       Date:  2002-12       Impact factor: 3.199

Review 7.  Visceral pain: the neurophysiological mechanism.

Authors:  Jyoti N Sengupta
Journal:  Handb Exp Pharmacol       Date:  2009

Review 8.  Neurokinin NK1 and NK3 receptors as targets for drugs to treat gastrointestinal motility disorders and pain.

Authors:  Gareth J Sanger
Journal:  Br J Pharmacol       Date:  2004-03-15       Impact factor: 8.739

Review 9.  The Role of Visceral Hypersensitivity in Irritable Bowel Syndrome: Pharmacological Targets and Novel Treatments.

Authors:  Mohammad H Farzaei; Roodabeh Bahramsoltani; Mohammad Abdollahi; Roja Rahimi
Journal:  J Neurogastroenterol Motil       Date:  2016-10-30       Impact factor: 4.924

Review 10.  Experimental Models of Irritable Bowel Syndrome and the Role of the Enteric Neurotransmission.

Authors:  Maria Giuliana Vannucchi; Stefano Evangelista
Journal:  J Clin Med       Date:  2018-01-03       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.